Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Cremers

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|January 8, 2020
Nulelìntàm èli PaèkwSerge Cremers
Drugs|November 23, 2006
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfallsSerge Cremers, Patrick Garnero
Annals of the New York Academy of Sciences|October 16, 2010
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the boneSerge Cremers, Azeez Farooki
Bone|February 2, 2011
Pharmacology of bisphosphonatesSerge Cremers, Socrates Papapoulos
British Journal of Clinical Pharmacology|June 28, 2017
Drugs for rare disordersSerge Cremers, Jeffrey K Aronson
British Journal of Clinical Pharmacology|April 9, 2021
Introduction to clinical pharmacology at largeEmma F Magavern, Serge Cremers
British Journal of Clinical Pharmacology|October 5, 2021
Concise advice: Introducing a new clinically focused BJCP series on evidence-based (de)prescribing in challenging situationsLauren E Walker, Serge Cremers
British Journal of Clinical Pharmacology|July 5, 2020
On precision dosing of oral small molecule drugs in oncologyAlex K Lyashchenko, Serge Cremers
British Journal of Clinical Pharmacology|January 29, 2019
Pharmacometrics and systems pharmacology for metabolic bone diseasesMatthew M Riggs, Serge Cremers
British Journal of Clinical Pharmacology|September 10, 2016
Therapeutic drug monitoring in the era of precision medicine: opportunities!Serge Cremers, Nishan Guha, Brian Shine
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|January 8, 2020
Nulelìntàm èli PaèkwSerge Cremers
Drugs|November 23, 2006
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfallsSerge Cremers, Patrick Garnero
Annals of the New York Academy of Sciences|October 16, 2010
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the boneSerge Cremers, Azeez Farooki
Bone|February 2, 2011
Pharmacology of bisphosphonatesSerge Cremers, Socrates Papapoulos
British Journal of Clinical Pharmacology|June 28, 2017
Drugs for rare disordersSerge Cremers, Jeffrey K Aronson
British Journal of Clinical Pharmacology|April 9, 2021
Introduction to clinical pharmacology at largeEmma F Magavern, Serge Cremers
British Journal of Clinical Pharmacology|October 5, 2021
Concise advice: Introducing a new clinically focused BJCP series on evidence-based (de)prescribing in challenging situationsLauren E Walker, Serge Cremers
British Journal of Clinical Pharmacology|July 5, 2020
On precision dosing of oral small molecule drugs in oncologyAlex K Lyashchenko, Serge Cremers
British Journal of Clinical Pharmacology|January 29, 2019
Pharmacometrics and systems pharmacology for metabolic bone diseasesMatthew M Riggs, Serge Cremers
British Journal of Clinical Pharmacology|September 10, 2016
Therapeutic drug monitoring in the era of precision medicine: opportunities!Serge Cremers, Nishan Guha, Brian Shine
Pageof 14